Clearwater Paper (CLW) to Release Quarterly Earnings on Monday

Clearwater Paper (NYSE:CLW) will announce its earnings results after the market closes on Monday, February 5th. Analysts expect the company to announce earnings of $0.92 per share for the quarter.

Clearwater Paper (CLW) opened at $47.35 on Monday. The company has a quick ratio of 0.43, a current ratio of 1.11 and a debt-to-equity ratio of 1.17. Clearwater Paper has a twelve month low of $42.20 and a twelve month high of $65.50. The company has a market capitalization of $778.12, a P/E ratio of 30.55, a P/E/G ratio of 3.09 and a beta of 1.02.

Get Clearwater Paper alerts:

A number of research firms recently commented on CLW. KeyCorp reissued a “hold” rating on shares of Clearwater Paper in a report on Thursday, October 12th. Zacks Investment Research cut Clearwater Paper from a “hold” rating to a “sell” rating in a report on Monday, October 9th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the company’s stock. Clearwater Paper has an average rating of “Hold” and an average target price of $60.00.

TRADEMARK VIOLATION NOTICE: “Clearwater Paper (CLW) to Release Quarterly Earnings on Monday” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/29/clearwater-paper-clw-to-release-quarterly-earnings-on-monday.html.

Clearwater Paper Company Profile

Clearwater Paper Corporation manufactures consumer tissue, away-from-home (AFH) tissue, parent roll tissue, bleached paperboard and pulp at manufacturing facilities across the nation. The Company operates through two segments: Consumer Products segment, and Pulp and Paperboard segment. The Company’s Consumer Products segment manufactures and sells a line of at-home tissue products, as well as AFH products.